The Clorox Company $CLX Shares Sold by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC trimmed its position in shares of The Clorox Company (NYSE:CLX) by 6.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 107,652 shares of the company’s stock after selling 7,900 shares during the quarter. Janney Montgomery Scott LLC owned 0.09% of Clorox worth $12,926,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in CLX. Wellington Management Group LLP increased its stake in shares of Clorox by 18.8% during the fourth quarter. Wellington Management Group LLP now owns 4,074 shares of the company’s stock worth $662,000 after acquiring an additional 646 shares during the period. NBC Securities Inc. grew its position in Clorox by 123,850.0% during the first quarter. NBC Securities Inc. now owns 2,479 shares of the company’s stock worth $365,000 after buying an additional 2,477 shares during the period. Merit Financial Group LLC grew its position in Clorox by 176.9% during the first quarter. Merit Financial Group LLC now owns 6,297 shares of the company’s stock worth $927,000 after buying an additional 4,023 shares during the period. RFG Advisory LLC grew its position in Clorox by 13.7% during the first quarter. RFG Advisory LLC now owns 2,406 shares of the company’s stock worth $354,000 after buying an additional 290 shares during the period. Finally, Hennion & Walsh Asset Management Inc. grew its position in Clorox by 56.2% during the first quarter. Hennion & Walsh Asset Management Inc. now owns 6,828 shares of the company’s stock worth $1,005,000 after buying an additional 2,456 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages have weighed in on CLX. TD Cowen lowered their target price on shares of Clorox from $120.00 to $117.00 and set a “hold” rating on the stock in a research report on Wednesday. Citigroup restated a “neutral” rating and set a $135.00 target price (down from $140.00) on shares of Clorox in a research report on Tuesday, July 15th. UBS Group lowered their target price on shares of Clorox from $150.00 to $134.00 and set a “neutral” rating on the stock in a research report on Thursday, July 17th. JPMorgan Chase & Co. upped their target price on shares of Clorox from $133.00 to $135.00 and gave the stock a “neutral” rating in a research report on Monday, September 8th. Finally, Wells Fargo & Company reduced their price target on shares of Clorox from $130.00 to $125.00 and set an “equal weight” rating on the stock in a report on Thursday, September 25th. One equities research analyst has rated the stock with a Buy rating, ten have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Reduce” and an average target price of $134.08.

Insider Activity

In other news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the sale, the chief operating officer owned 54,221 shares of the company’s stock, valued at $6,711,475.38. This represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.57% of the stock is owned by insiders.

Clorox Price Performance

Clorox stock opened at $123.30 on Friday. The Clorox Company has a 52-week low of $116.53 and a 52-week high of $171.37. The firm has a fifty day moving average of $122.81 and a 200-day moving average of $129.64. The firm has a market capitalization of $15.08 billion, a P/E ratio of 18.91, a PEG ratio of 0.98 and a beta of 0.52. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15.

Clorox (NYSE:CLX) last released its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.94 billion. During the same quarter in the prior year, the business earned $1.82 earnings per share. The business’s quarterly revenue was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be given a $1.24 dividend. The ex-dividend date of this dividend is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a dividend yield of 4.0%. Clorox’s dividend payout ratio is presently 76.07%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.